Table of Contents

2019-2024 Global Polio Vaccine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Polio Vaccine Consumption 2014-2024
  • 2.1.2 Polio Vaccine Consumption CAGR by Region
• 2.2 Polio Vaccine Segment by Type
  • 2.2.1 Inactivated Polio Vaccine (IPV)
  • 2.2.2 Oral Polio Vaccine (OPV)
• 2.3 Polio Vaccine Consumption by Type
  • 2.3.1 Global Polio Vaccine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Polio Vaccine Sale Price by Type (2014-2019)
• 2.4 Polio Vaccine Segment by Application
  • 2.4.1 Public
  • 2.4.2 Private
• 2.5 Polio Vaccine Consumption by Application
  • 2.5.1 Global Polio Vaccine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Polio Vaccine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Polio Vaccine Sale Price by Application (2014-2019)

3 Global Polio Vaccine by Players

• 3.1 Global Polio Vaccine Sales Market Share by Players
  • 3.1.1 Global Polio Vaccine Sales by Players (2017-2019)
  • 3.1.2 Global Polio Vaccine Sales Market Share by Players (2017-2019)
• 3.2 Global Polio Vaccine Revenue Market Share by Players
  • 3.2.1 Global Polio Vaccine Revenue by Players (2017-2019)
  • 3.2.2 Global Polio Vaccine Revenue Market Share by Players (2017-2019)
• 3.3 Global Polio Vaccine Sale Price by Players
• 3.4 Global Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Polio Vaccine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Polio Vaccine by Regions

• 4.1 Polio Vaccine by Regions
  • 4.1.1 Global Polio Vaccine Consumption by Regions
  • 4.1.2 Global Polio Vaccine Value by Regions
• 4.2 Americas Polio Vaccine Consumption Growth
• 4.3 APAC Polio Vaccine Consumption Growth
• 4.4 Europe Polio Vaccine Consumption Growth
• 4.5 Middle East & Africa Polio Vaccine Consumption Growth

5 Americas

• 5.1 Americas Polio Vaccine Consumption by Countries
  • 5.1.1 Americas Polio Vaccine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Polio Vaccine Value by Countries (2014-2019)
• 5.2 Americas Polio Vaccine Consumption by Type
• 5.3 Americas Polio Vaccine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Polio Vaccine Consumption by Countries
  • 6.1.1 APAC Polio Vaccine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Polio Vaccine Value by Countries (2014-2019)
• 6.2 APAC Polio Vaccine Consumption by Type
• 6.3 APAC Polio Vaccine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Polio Vaccine by Countries
  • 7.1.1 Europe Polio Vaccine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Polio Vaccine Value by Countries (2014-2019)
• 7.2 Europe Polio Vaccine Consumption by Type
• 7.3 Europe Polio Vaccine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Polio Vaccine by Countries
  • 8.1.1 Middle East & Africa Polio Vaccine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Polio Vaccine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Polio Vaccine Consumption by Type
• 8.3 Middle East & Africa Polio Vaccine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Polio Vaccine Distributors
• 10.3 Polio Vaccine Customer

11 Global Polio Vaccine Market Forecast

• 11.1 Global Polio Vaccine Consumption Forecast (2019-2024)
• 11.2 Global Polio Vaccine Forecast by Regions
  • 11.2.1 Global Polio Vaccine Forecast by Regions (2019-2024)
  • 11.2.2 Global Polio Vaccine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Polio Vaccine Forecast by Type
• 11.8 Global Polio Vaccine Forecast by Application

12 Key Players Analysis

• 12.1 Sanofi
  • 12.1.1 Company Details
  • 12.1.2 Polio Vaccine Product Offered
  • 12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Sanofi News
• 12.2 GSK
  • 12.2.1 Company Details
  • 12.2.2 Polio Vaccine Product Offered
  • 12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 GSK News
• 12.3 Bibcol
  • 12.3.1 Company Details
  • 12.3.2 Polio Vaccine Product Offered
  • 12.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Bibcol News
• 12.4 Serum Institute
  • 12.4.1 Company Details
  • 12.4.2 Polio Vaccine Product Offered
  • 12.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Serum Institute News
• 12.5 Tiantan Biological
  • 12.5.1 Company Details
  • 12.5.2 Polio Vaccine Product Offered
  • 12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Tiantan Biological News
• 12.6 IMBCA
  • 12.6.1 Company Details
  • 12.6.2 Polio Vaccine Product Offered
  • 12.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 IMBCA News
• 12.7 Panacea Biotec Ltd
  • 12.7.1 Company Details
  • 12.7.2 Polio Vaccine Product Offered
  • 12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Panacea Biotec Ltd News
• 12.8 Bio-Med
  • 12.8.1 Company Details
  • 12.8.2 Polio Vaccine Product Offered
  • 12.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Bio-Med News
• 12.9 Halfkin Bio-Pharmaceuticals
  • 12.9.1 Company Details
  • 12.9.2 Polio Vaccine Product Offered
  • 12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Halfkin Bio-Pharmaceuticals News

13 Research Findings and Conclusion

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.

According to this study, over the next five years the Polio Vaccine market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 1630 million by 2024, from US$ 1210 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Polio Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Polio Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Public
Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Polio Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Polio Vaccine market by identifying its various subsegments.
Focuses on the key global Polio Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Polio Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Polio Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.